abstract |
(S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidine-3- Il)-3-hydroxypyrrolidine-1-carboxamide, a pharmaceutically acceptable salt thereof, or a liquid formulation of a combination thereof and said liquid formulation in the treatment of pain, cancer, inflammation, and certain infectious diseases The use of is disclosed. |